BLTE belitebio.com Expected net earnings per share growth this year

BLTE (Belite Bio, Inc) - company brandmark

Belite Bio, Inc (BLTE) is a reputable developer of advanced therapies for rare visual pathologies. On GURU.Markets, the volatility of annual earnings per share illustrates EPS dynamics, where the figure stands at -31.90. Certified contract manufacturing capacities are currently focused on producing pilot batches for clinical use. High scaling potential is driven by the global implementation of patented drug formulas.

BLTE: belitebio.com Earnings growth in current year 04/28/2023 - 11/15/2026

Financial and market metric breakdowns for Belite Bio, Inc. (BLTE)

- stock value and consensus price forecast:
Market Price belitebio.com|BLTE - Price Target Chart
- market capitalization data:
Market Capitalization Belite Bio|BLTE - Enterprise Value
- shareholders' equity book value data:
Net Assets per Single Share Belite Bio|BLTE - Book Capitalization|Market-to-Book Ratio belitebio.com|BLTE - Aggregate Company Assets
- debt burden and liquidity indicators:
Debt to Equity Belite Bio, Inc|BLTE - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Belite Bio Corp|BLTE - Company Total Debt|Debt to Book Capital Belite Bio|BLTE - Company Long-Term Debts|Short-Term Debt Belite Bio|Intermediate Coverage Ratio belitebio.com
- earnings and valuation multiples information:
BLTE - Net Profit|Expected Profit Belite Bio, Inc|BLTE - P/E Multiple|Market Cap to Projected Earnings Belite Bio, Inc|BLTE - Price/Earnings to Growth Ratio|Company Value to EBITDA Belite Bio Inc|BLTE - Operating profit before deduction of amortization|Earnings per share for the trailing year Belite Bio|BLTE - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months belitebio.com|BLTE - Earnings per share growth in current year|Projected earnings per share growth rate for next year Belite Bio, Inc
- sales volume and revenue information:
BLTE - Revenue and Sales Volume|Company Future Sales Volume Belite Bio|BLTE - P/S Multiple|Price-to-Projected Revenue Ratio Belite Bio, Inc.|BLTE - Sales Growth YoY (Last Twelve Months)
Summary company analysis:Belite Bio Corp - BLTE
Finished products of Belite Bio

This indicator measures the annual dynamics of net earnings per share, excluding seasonal fluctuations to identify the true profitability trend. By analyzing the annual EPS change, an investor assesses capitalization efficiency, which is critical for Belite Bio, Inc (BLTE) amidst intense scientific competition with pharma behemoths for leadership in the therapy of rare ocular pathologies.

Direct competitors

ALC - Expected net earnings per share growth this year|Earnings per share growth in current year bausch.com|Glaukos Corporation (GKOS) - Expected net earnings per share growth this year|Earnings growth in current year APLS|OCUL - Earnings per share growth rate in current year|Earnings growth in current year HROW (Harrow Inc)|Expected net earnings per share growth this year Viridian Corp (VRDN)|LENZ - Earnings per share growth in current year|Oculis - Net earnings per one share growth for the current year|EyePoint Pharmaceuticals (EYPT) - Earnings per share growth in current year|Kodiak Sciences Inc (KOD) - Earnings growth in current year|Net earnings per share growth this year ALDX|KALA: Earnings per share increase in current year|Earnings growth in current year IRD|OKYO: Earnings per share trend in current year|Earnings per share growth in current year Adverum Biotechnologies ADVM|Earnings growth in current year Outlook Pharma OTLK|Clearside Biomedical - Earnings growth in current year|Earnings per share trend in current year NBY|KPRX: Earnings growth in current year|ALIM - Expected net earnings per share growth this year|EYEN (Eyenovia) - Earnings growth in current year|GHSI: Earnings per share increase in current year|Earnings growth in current year OCUP|Net earnings per one share growth for the current year OPT